ArticlePryon Closes $100 Million Series BCooley advised Pryon, the pioneer in bringing artificial intelligence to knowledge management, on the close of its Series B financing at $100 million.United StatesCorporate/Commercial LawCooley LLP
ArticleEnglish Court Clarifies Test For Forseeability RiskThe ruling provides food for thought to those managing new risks.United StatesLitigation, Mediation & ArbitrationCooley LLP
Article'Compliance & Legal Risk' Podcast – Travis LeBlanc And Randy SabettCooley's Travis LeBlanc and Randy Sabett provide insights on privacy law under different regimes, including GDPR, CCPA and more, in an installment of "Compliance & Legal Risk," ...United StatesPrivacyCooley LLP
ArticleTechnology MergersCovid-19 has made 2020 into a year like no other with 'stay at home' orders and working from home the new normal.United StatesAntitrust/Competition LawCooley LLP
Article2023 Financial Staleness And Filing GuideAs we approach the end of 2022, many companies are looking toward 2023 for initial public offerings and other public financing transactions. Among the most commonly asked questions...United StatesCorporate/Commercial LawCooley LLP
ArticleDefy.vc Closes Third Fund At $300 MillionCooley advised Defy.vc, an early-stage venture capital firm in Silicon Valley, on its third fund at $300 million to invest in seed and Series A rounds. United StatesCorporate/Commercial LawCooley LLP
ArticleHuman Capital Filings More ‘Art' Than ‘Science'"Amid a sweeping public health crisis, the SEC last month directed companies to consider human capital-related disclosures in annual reports and summarize risk factors...United StatesCorporate/Commercial LawCooley LLP
ArticleNeogene Therapeutics To Sell To AstraZenecaCooley advised Neogene Therapeutics, a global clinical-stage biotechnology company, ..United StatesCorporate/Commercial LawCooley LLP
ArticleViking Therapeutics Announces $632.5 Million Public Offering Of Common StockCooley advised the underwriters of Viking Therapeutics (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders...United StatesCorporate/Commercial LawCooley LLP
Video[Video] Biotech Financing Environment And Deal ConsiderationsAgainst the backdrop of a prolonged global pandemic, international conflict and a shifting economic climate, the capital markets landscape is ever-changing. Cooley brings you a quarterly...United StatesFinance and BankingCooley LLP
ArticleMedtech Primer On The FDA Regulatory Landscape"Medtech companies are subject to FDA regulation as medical device manufacturers if their products satisfy the 'device' definition in the Federal Food, Drug and Cosmetic Act (FDCA).United StatesFood, Drugs, Healthcare, Life SciencesCooley LLP
ArticleStructure Therapeutics – $185.3 Million IPOThe offering marks the first sizable US life sciences IPO this year. United StatesFood, Drugs, Healthcare, Life SciencesCooley LLP
ArticleIP Protection For Vegetatively Reproduced Plants: New Paths Forward"All of the important fruit-crop plants in the United States and many of ornamentals, potatoes, and several nut and forest trees are primarily reproduced through vegetative (asexual) meansUnited StatesIntellectual PropertyCooley LLP
ArticleThis Big Law Litigator Has Real Doubts About Virtual Jury Trials. Here's Why He's A SkepticMike Attanasio, head of Cooley's global litigation department, sat down with Alaina Lancaster to discuss what gets lost in a virtual proceeding and shared the one thing...United StatesLitigation, Mediation & ArbitrationCooley LLP
ArticleMeet The Top 10 Proptech Lawyers Minting Big Deals And Helping Real-Estate Startups Raise CashCooley partners Greg Grossman and Kevin Rooney have been recognized by Markets Insider as top proptech lawyers for helping startups and VCs mint big deals and snap up funding.United StatesReal Estate and ConstructionCooley LLP
ArticleHighlights From The 2022 Berkeley Fall Forum On Corporate GovernanceOn November 8 and 9, Cooley and the Berkeley Center for Law and Business presented the 2022 Berkeley Fall Forum on Corporate Governance. The two-day event featured...United StatesCorporate/Commercial LawCooley LLP
ArticleCooley Continues Life Sciences Partnering Growth On East CoastNew York – September 9, 2021 – Alan Tamarelli has joined Cooley as a partner in the firm's life sciences corporate partnering & licensing practice in New York. United StatesFood, Drugs, Healthcare, Life SciencesCooley LLP
ArticleCooley Files Supreme Court Amicus Brief To Preserve Discretion In Immigration EnforcementFiled on behalf of administrative law professors, the brief seeks reversal of the Fifth Circuit's decision in United States v. Texas striking down federal immigration enforcement priorities.United StatesImmigrationCooley LLP
ArticleProductwise Live: Looking To The Green Frontier – Key EU Developments For Green Claims, Products, Packaging And TextilesCurious to learn more about the European Commission's proposals and initiatives striving to achieve a circular economy? Join the Cooley international products team for a 30-minute rapid-fire...European UnionEnvironmentCooley LLP
ArticleUS Supreme Court Upholds FCC's Modernized Television Station Ownership Rules, Affirming Cooley Amicus BriefsThe US Supreme Court ruled on April 1 that the Federal Communications Commission was within its authority to repeal or modify three long-standing media ownership controls. United StatesMedia, Telecoms, IT, EntertainmentCooley LLP